Enanta Pharmaceuticals Current Cash

Enanta Pharmaceuticals (ENTA) currently reports a current cash of $35M as of March 2026. That compares with $60M in the prior-year period — down 42.0% year over year. Use the charts on this page to explore Enanta Pharmaceuticals's current cash history and peer comparisons.

Enanta Pharmaceuticals's current cash decreased from $60M to $35M — a 42.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enanta Pharmaceuticals reported $35M in current cash as of March 2026. That compares with $60M in the prior-year period — down 42.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enanta Pharmaceuticals, and consider following ENTA for alerts when major investors trade the stock.

Enanta Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENTA with unrelated industries.